Management of Acute Asthma in Pediatrics
Immediately administer high-flow oxygen via face mask, nebulized salbutamol 5 mg (or 2.5 mg in very young children), and oral prednisolone 1-2 mg/kg (maximum 40 mg) within the first few minutes of presentation for any child with acute severe asthma. 1, 2
Initial Assessment and Recognition
Recognize acute severe asthma in children by the following clinical features:
- Too breathless to talk or feed 1
- Respiratory rate >50 breaths/minute 1
- Heart rate >140 beats/minute 1
- Peak expiratory flow (PEF) <50% predicted (if measurable in children ≥5 years) 1
Life-threatening features requiring immediate aggressive intervention include:
- PEF <33% predicted or poor respiratory effort 1
- Silent chest, cyanosis, or fatigue/exhaustion 1
- Agitation or reduced level of consciousness 1
Critical pitfall: Children with severe attacks may not appear distressed, and assessment in very young children may be difficult—the presence of any single feature should alert you to severity. 1
Immediate Treatment Protocol (First 15-30 Minutes)
Oxygen Therapy
- Administer high-flow oxygen (40-60%) via face mask immediately 1, 2, 3
- Maintain oxygen saturation >92% with continuous pulse oximetry 1, 2
- CO2 retention is not aggravated by oxygen therapy in asthma 1
Bronchodilator Therapy
Nebulized beta-agonist is the primary bronchodilator:
- Salbutamol 5 mg via oxygen-driven nebulizer (use 2.5 mg in very young children) 1, 2, 3
- Alternative: Terbutaline 10 mg via nebulizer (5 mg in very young children) 1, 3
Alternative delivery method with equivalent efficacy:
- Metered-dose inhaler (MDI) with large volume spacer: 1 puff every few seconds up to 10-20 puffs maximum 1, 2
- Use a face mask with the spacer in very young children 1
- This method is supported by high-quality evidence showing comparable efficacy to nebulization with shorter treatment times and fewer adverse effects 4, 5
Systemic Corticosteroids
Administer corticosteroids immediately—do not delay:
- Oral prednisolone 1-2 mg/kg body weight (maximum 40 mg) 1, 2, 3
- If child is vomiting or severely ill: Intravenous hydrocortisone 200 mg 1, 2
Anticholinergic Therapy
- Add ipratropium 100 mcg (0.1 mg) to nebulizer, repeat every 6 hours 1, 3
- Can be mixed in the same nebulizer with salbutamol 2
Reassessment at 15-30 Minutes
Measure and document the following:
- Peak expiratory flow rate (if appropriate for age) 1, 2
- Oxygen saturation 1, 2
- Respiratory rate and heart rate 2
- Clinical appearance and work of breathing 2
If Patient is Improving:
- Continue high-flow oxygen 1
- Continue prednisolone 1-2 mg/kg daily (maximum 40 mg) 1
- Continue nebulized beta-agonist every 4 hours 1
If Patient is NOT Improving:
- Continue oxygen and steroids 1
- Increase nebulized beta-agonist frequency to every 15-30 minutes 1, 2
- Continue ipratropium every 6 hours until improvement begins 1
- Consider continuous nebulization 2
Life-Threatening Features: Additional Management
If life-threatening features are present, add:
- Intravenous aminophylline: 5 mg/kg loading dose over 20 minutes, followed by 1 mg/kg/hour maintenance infusion 1
- Critical caveat: Omit the loading dose if the child is already receiving oral theophyllines 1
Monitoring Throughout Treatment
Continuous monitoring includes:
- Pulse oximetry to maintain SaO2 >92% 1, 2, 3
- Chart PEF before and after each beta-agonist administration and at least 4 times daily 1, 3
- Respiratory rate and heart rate 2
- Clinical assessment of work of breathing and mental status 2
Blood gas measurements are rarely helpful in deciding initial management in children. 1
Critical Pitfalls to Avoid
- Never give sedatives of any kind—they can precipitate respiratory failure 1, 2
- Do not delay systemic corticosteroids—they should be given immediately 2
- Do not underestimate severity—children may not appear distressed despite severe obstruction 1
- Avoid inadequate oxygen delivery—use high-flow systems 2
Criteria for ICU Transfer
Transfer to intensive care unit if:
- Deteriorating PEF despite treatment 1, 2
- Worsening or persistent hypoxia 1, 2
- Exhaustion, feeble respirations, confusion, or drowsiness 1, 2
- Coma or respiratory arrest 1
The patient should be accompanied by a physician prepared to intubate. 1
Discharge Criteria
Before discharge, ensure:
- Patient has been on discharge medication for 24 hours 1, 3
- Inhaler technique has been checked and recorded 1, 3
- PEF >75% of predicted or best (if measurable) 1, 3
- PEF diurnal variability <25% 1, 3
- Treatment plan includes oral corticosteroids (continue for 3-5 days), inhaled corticosteroids, and bronchodilators 1, 3
- Written self-management plan provided 1
- GP follow-up arranged within 1 week 1
- Respiratory clinic follow-up within 4 weeks 1
Evidence Considerations
The British Thoracic Society guidelines provide the foundational framework for pediatric acute asthma management. 1 Recent meta-analyses demonstrate that MDI with spacer is equally effective as nebulization, with advantages including shorter treatment times (66 vs 103 minutes), fewer episodes of vomiting (9% vs 20%), and smaller increases in heart rate. 4, 5 However, nebulizers remain the standard in most emergency settings and are explicitly recommended in the guidelines. 1, 3